FDA Inspection 1238442 - Aurobindo Pharma USA Inc - May 15, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Aurobindo Pharma USA Inc

Record Details

This FDA Inspection record concerns Aurobindo Pharma USA Inc, with an inspection on May 15, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Aurobindo Pharma USA Inc
Inspection Date: May 15, 2024
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 653906f9-7952-4bff-9baa-c6b093dcc401

Violation Codes2

FDCA 582(b)(4)FDCA 582(b)(4)(B)(ii)(I)

Full citation text and observation details available on the Dashboard.